These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7748462)

  • 1. Neuron specific enolase in cerebrospinal fluid: a biochemical marker for neuronal degeneration in dementia disorders?
    Blennow K; Wallin A; Ekman R
    J Neural Transm Park Dis Dement Sect; 1994; 8(3):183-91. PubMed ID: 7748462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid neuron-specific enolase in Alzheimer's disease and vascular dementia.
    Parnetti L; Palumbo B; Cardinali L; Loreti F; Chionne F; Cecchetti R; Senin U
    Neurosci Lett; 1995 Jan; 183(1-2):43-5. PubMed ID: 7746484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid neuron-specific enolase: a further marker of Alzheimer's disease?
    Palumbo B; Siepi D; Sabalich I; Tranfaglia C; Parnetti L
    Funct Neurol; 2008; 23(2):93-6. PubMed ID: 18671910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated levels of cerebrospinal fluid neuron-specific enolase (NSE) in Alzheimer's disease.
    Schmidt FM; Mergl R; Stach B; Jahn I; Gertz HJ; Schönknecht P
    Neurosci Lett; 2014 Jun; 570():81-5. PubMed ID: 24746933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid neuron-specific enolase is decreased in multi-infarct dementia, but unchanged in Alzheimer's disease.
    Sulkava R; Viinikka L; Erkinjuntti T; Roine R
    J Neurol Neurosurg Psychiatry; 1988 Apr; 51(4):549-51. PubMed ID: 3379429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid neuron-specific enolase is reduced in Alzheimer's disease.
    Cutler NR; Kay AD; Marangos PJ; Burg C
    Arch Neurol; 1986 Feb; 43(2):153-4. PubMed ID: 3947256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ubiquitin in cerebrospinal fluid in Alzheimer's disease and vascular dementia.
    Blennow K; Davidsson P; Wallin A; Gottfries CG; Svennerholm L
    Int Psychogeriatr; 1994; 6(1):13-22; discussion 59-60. PubMed ID: 8054491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromogranin A in cerebrospinal fluid: a biochemical marker for synaptic degeneration in Alzheimer's disease?
    Blennow K; Davidsson P; Wallin A; Ekman R
    Dementia; 1995; 6(6):306-11. PubMed ID: 8563783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis of cerebrospinal fluid neuron-specific enolase levels in Alzheimer's disease, Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy.
    Katayama T; Sawada J; Takahashi K; Yahara O; Hasebe N
    Alzheimers Res Ther; 2021 Oct; 13(1):163. PubMed ID: 34610837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurodegeneration and Glial Activation Related CSF Biomarker as the Diagnosis of Alzheimer's Disease: A Systematic Review and an Updated Meta- analysis.
    Hao Y; Liu X; Zhu R
    Curr Alzheimer Res; 2022; 19(1):32-46. PubMed ID: 34879804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevation of neuron-specific enolase in serum and cerebrospinal fluid of early stage Creutzfeldt-Jakob disease.
    Kohira I; Tsuji T; Ishizu H; Takao Y; Wake A; Abe K; Kuroda S
    Acta Neurol Scand; 2000 Dec; 102(6):385-7. PubMed ID: 11125754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuron-specific enolase in patients with acute ischemic stroke and related dementia.
    Li Y; Wang X; Yang Z
    Chin Med J (Engl); 1995 Mar; 108(3):221-3. PubMed ID: 7796631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuron-specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children.
    Berger RP; Pierce MC; Wisniewski SR; Adelson PD; Clark RS; Ruppel RA; Kochanek PM
    Pediatrics; 2002 Feb; 109(2):E31. PubMed ID: 11826241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid neurone-specific enolase in mitochondrial encephalomyopathies.
    Finsterer J; Exner M; Rumpold H
    Metab Brain Dis; 2005 Mar; 20(1):81-6. PubMed ID: 15918553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated levels of cerebrospinal fluid neuron-specific enolase (NSE), but not S100B in major depressive disorder.
    Schmidt FM; Mergl R; Stach B; Jahn I; Schönknecht P
    World J Biol Psychiatry; 2015 Feb; 16(2):106-13. PubMed ID: 25264292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Level of S-100 and neuron-specific enolase in cerebrospinal fluid from subjects with neurological pathologies].
    Infante JR; Martínez A; Ochoa J; Cañadillas F; Torres-Avisbal M; Vallejo JA; González FM; Pacheco C; Latre JM
    Rev Esp Med Nucl; 2003; 22(4):238-43. PubMed ID: 12846948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal CSF neuron-specific enolase and S-100 protein levels in patients with recent non-complicated tonic-clonic seizures.
    Palmio J; Peltola J; Vuorinen P; Laine S; Suhonen J; Keränen T
    J Neurol Sci; 2001 Jan; 183(1):27-31. PubMed ID: 11166790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A more sensitive radioimmunoassay for neuron-specific enolase suitable for cerebrospinal fluid determinations.
    Parma AM; Marangos PJ; Goodwin FK
    J Neurochem; 1981 Mar; 36(3):1093-6. PubMed ID: 7205259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical relevance of increased neuron-specific enolase concentration in cerebrospinal fluid.
    Jacobi C; Reiber H
    Clin Chim Acta; 1988 Sep; 177(1):49-54. PubMed ID: 3052937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum and cerebrospinal fluid neuron-specific enolase for diagnosis of tuberculous meningitis.
    Song TJ; Choi YC; Lee KY; Kim WJ
    Yonsei Med J; 2012 Nov; 53(6):1068-72. PubMed ID: 23074103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.